Last reviewed · How we verify

NCT05275283

Efficacy Evaluation of Positive End-expiratory Pressure in Children Undergoing Mechanical Ventilation Using Supraglottic Airway Device

Status unknown NA Last updated 11 March 2022
What this trial tests

NA trial testing PEEP in Positive End Expiratory Pressure in 94 participants. Status unknown.

Timeline
3 January 2022
Primary endpoint
30 December 2023
30 December 2023

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment94
Start date3 January 2022
Primary completion30 December 2023
Estimated completion30 December 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Under 6, any sex, with Positive End Expiratory Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine whether application of positive end-expiratory pressure (PEEP) improves respiratory data including respiratory compliance in children who receive positive pressure ventilation using supraglottic airway device (SAD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PEEP

Trials testing the same drug.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05275283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing